ACCESS Newswire
09 Apr 2021, 21:13 GMT+10
CAPE TOWN, SA / ACCESSWIRE / April 9, 2021 / WUHAN GENERAL GROUP, INC. (OTC:WUHN) ('Wuhan' or the 'Company'), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following update regarding its latest brand offering:
We are thrilled to introduce our upcoming brand LivianaTM which is set to launch in May 2021. The LivianaTM brand will kick off its product line with a range of three spectacular CBD infused olive oils:
These remarkable olive oils will be bottled at source from the Falcon's Nest Farm owned by Chaloner Estates which is beautifully nestled on the Stellenbosch Mountains slopes, Cape Town, South Africa. The olive oils produced by the Chaloner team have won multiple awards for their exceptional quality. The new LivianaTM formulations have passed the final taste test and will be available in the markets very soon.
'It's been great fun and educational to work with Jeff and the M2BIO Sciences team in developing the three variants. I had no idea the science behind CBD is so fascinating and compelling. In addition, they care deeply about delivering a premium product to consumers which hugely resonated with Chaloner. We look forward to furthering unique collaborations in the near future. ' said Perry Chaloner, Chaloner Estates Managing Director.
'There is a plethora of great science that shows the enormous benefits for those that follow the Mediterranean Diet versus those that don't. Olive oil consumption is a big part of the diet. Introducing a CBD infusion into the olive oil gives it a one-two knock-out punch that makes for an exceptionally healthy product. And the flavors? Heaven-sent. ' said Jeff Robinson Wuhan General Group CEO.
LivianaTM olive oils have no added artificial flavorings, colors or MSG and will be produced, bottled and packaged in a sustainable and conscientious manner. The Wuhan and Chaloner teams are united by their dedication to doing their part in helping make the planet a better, safer and cleaner place, one day at a time.
About Wuhan General Group, Inc./ M2Bio Sciences, Inc
Wuhan General Group, Inc. through its wholly owned subsidiary MJ MedTech is a nutraceutical biotechnology company that researches, develops and commercializes a range of CBD-based products under Dr. AnnaRx™, Medspresso™, LivianaTM and Handcrafted Delights™ brands. In addition, its wholly owned division, M2Bio is researching and developing indications for psilocybin new therapies that will help patients who suffer from addiction, mental illness, Alzheimer's and Parkinson's. Our mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research and emerging technologies. Wuhan is listed and traded on the Over-the-Counter Bulletin Board of NASDAQ under the trading symbol 'WUHN'.
For further information:
Publicly traded company (OTC Pink:WUHN)
Website: www.m2bio.co
E-mail: [email protected]
Follow us on Twitter: https://twitter.com/m2bio
Follow us on Facebook: http://www.facebook.com/m2bio
Forward-Looking Statements:
Safe Harbour Statement - In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward-looking statements.
SOURCE: Wuhan General Group, Inc./ M2Bio Sciences, Inc.
Get a daily dose of Memphis Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Memphis Sun.
More InformationWASHINGTON, DC - U.S. President Donald Trump on Tuesday claimed Elon Musk's success has been built on government subsidies. Without...
EVERGLADES, Florida: Over the weekend, a diverse coalition of environmental activists, Native American leaders, and residents gathered...
BEIJING, China: China's national soccer team may struggle to stir excitement, but its humanoid robots are drawing cheers — and not...
]LONDON, U.K.: A World Health Organization (WHO) expert group investigating the origins of the COVID-19 pandemic released its final...
DOVER, Delaware: California Governor Gavin Newsom has taken legal aim at Fox News, accusing the network of deliberately distorting...
FRANKFURT, Germany: Germany has become the latest country to challenge Chinese AI firm DeepSeek over its data practices, as pressure...
SANTA CLARA, California: Executives at Nvidia have quietly been cashing in on the AI frenzy. According to a report by the Financial...
NEW YORK, New York - Global stock indices closed with divergent performances on Tuesday, as investors weighed corporate earnings, central...
TORONTO, Canada: Canadian Prime Minister Mark Carney announced late on June 29 that trade negotiations with the U.S. have recommenced...
Vancouver, Canada: A high-stakes legal showdown is brewing in the world of athleisure. Lululemon, the Canadian brand known for its...
LONDON, U.K.: British oil giant Shell has denied reports that it is in talks to acquire rival oil company BP. The Wall Street Journal...
NEW YORK, New York - U.S. stock markets closed firmly in positive territory to start the week Monday, with the S&P 500 and Dow Jones...